• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Earnings Beat, Dividend Hike and Buybacks At Reinsurance Group of America (RGA) Have Changed Its Investment Story

    Simply Wall St·08/15/2026 23:25:00
    Listen to the news
    • In the past quarter, Reinsurance Group of America, Incorporated reported higher second-quarter 2026 revenue of US$6.64 billion and net income of US$462 million, alongside stronger earnings per share versus a year earlier. The company also raised its regular quarterly dividend to US$0.98 and completed nearly US$100 million of share repurchases under its 2026 buyback program, highlighting an increased focus on shareholder returns.
    • Beyond the headline earnings jump, the combination of higher investment returns, solid underwriting performance and an increased dividend signals how management is deploying capital to balance business growth with enhanced cash returns to investors.
    • Next, we will examine how this earnings outperformance and dividend increase affects Reinsurance Group of America’s existing investment narrative and risk profile.

    Uncover the next big thing with 18 elite penny stocks that balance risk and reward.

    Reinsurance Group of America Investment Narrative Recap

    To own Reinsurance Group of America, you need to believe in its role as a specialist life and health reinsurer that converts disciplined underwriting and data-driven solutions into steady earnings and measured capital returns. The latest quarter’s stronger revenue and net income, plus higher EPS, support this narrative in the near term, though claims volatility and evolving healthcare costs remain the key short term swing factors for results. Overall, this report does not materially change that core thesis.

    Among the recent announcements, the 5.4% increase in the regular quarterly dividend to US$0.98 per share stands out in the context of RGA’s earnings strength. Together with nearly US$100 million of completed buybacks under the 2026 program, it reflects how current profitability is supporting higher ongoing cash returns, which many investors view as a near term catalyst for interest in the stock, alongside continued attention to underwriting performance.

    Yet behind the strong dividend and buybacks, investors should be aware that rising healthcare excess claims and medical cost inflation could still...

    Read the full narrative on Reinsurance Group of America (it's free!)

    Reinsurance Group of America's narrative projects $31.2 billion revenue and $2.0 billion earnings by 2029. This requires 7.7% yearly revenue growth and a $0.8 billion earnings increase from $1.2 billion today.

    Uncover how Reinsurance Group of America's forecasts yield a $261.78 fair value, a 5% upside to its current price.

    Exploring Other Perspectives

    RGA 1-Year Stock Price Chart
    RGA 1-Year Stock Price Chart

    Some of the most optimistic analysts were already expecting earnings near US$2.3 billion by 2029, and this quarter’s strong results may either reinforce or challenge that view, especially if you are weighing that upbeat outlook against the risk of persistent claims volatility that could unsettle future profit trends.

    Explore 2 other fair value estimates on Reinsurance Group of America - why the stock might be worth over 3x more than the current price!

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    • A great starting point for your Reinsurance Group of America research is our analysis highlighting 4 key rewards that could impact your investment decision.
    • Our free Reinsurance Group of America research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Reinsurance Group of America's overall financial health at a glance.

    Curious About Other Options?

    The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.